Photo of Dr. Robert J. DiDomenico

Robert J. DiDomenico


Associate Professor, Pharmacy Practice
Interim Assistant Head, Pharmacy Practice

Contact

Building & Room:

121

Address:

833 S. Wood Street, Chicago, IL, 60612

Office Phone:

(312) 996-1342

Fax:

(312) 996-0379

Email:

rdidom1@uic.edu

CV Link:

Robert J. DiDomenico

Related Sites:

About

Research Interests: The focus of my research is optimizing the use of evidence-based therapies in patients patients with cardiovascular disease, particularly those with heart failure and acute coronary syndrome.
Teaching Interests: My teaching interests include adoption of innovative methods to engage students, improving item-writing for student assessment, and experiential teaching of student pharmacists and pharmacy residents.
Clinical Interests: I have been a clinical pharmacist on an inpatient general cardiology service for more than 20 years, caring for patients on both step-down and intensive care units.

Selected Publications

  • Reed BN, DiDomenico RJ, Allender JE, Coons JC, Cox JF, Johnson D, Oliphant CS, Jennings DL. Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high-volume centers. J Interv Cardiol. 2019;2019(3791307). doi:https://doi.org/10.1155/2019/3791307.

  • Gasbarro NM, DiDomenico RJ. Frequency of “on-label” use of intravenous diltiazem for rate control in patients with acute-onset atrial fibrillation or atrial flutter. Am J Health-Syst Pharm. 2019;76:214-20. doi:https://doi.org/10.1093/ajhp/zxy033.

  • DiDomenico RJ. (2018). “Cardiology clinical pharmacy practice–keep spreading the news!”. JACCP. Vol. 1. Page(s) 54-55. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1048

  • Kim K, Lee TA, Touchette D, DiDomenico RJ, Ardati AK, Walton SM. “Comparison of 6-month costs between oral antiplatelet agents following acute coronary syndrome”. Journal of Managed Care and Specialty Pharmacy. 2018;24(8):800-812. doi:10.18553/jmcp.2018.24.8.800.

  • DiDomenico RJ. (2018). “Need for a universal residency application deadline”. American Journal of Health-System Pharmacy. Vol. 75. Issue 12. Page(s) 849-850. https://api.elsevier.com/content/abstract/scopus_id/85048195814

  • Zueger PM, Kumar VM, Harrington RL, Rigoni GC, Atwood A, DiDomenico RJ, Touchette D. Cost-Effectiveness Analysis of Sacubitril-Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States.. Pharmacotherapy. . doi:10.1002/phar.2108.

  • Baker WL, DiDomenico RJ, Haines ST. Improving Peer Review: What Authors Can Do.. American Journal Health-System Pharmacists. 74(24):2076-9. doi:10.2146/ajhp170190.

  • Haines ST, Baker WL, DiDomenico RJ. Improving Peer Review: What Journals Can Do.. American Journal of Health-System Pharmacists. 74(24):2086-9. doi:10.2146/ajhp170188.

  • DiDomenico RJ, Baker WL, Haines ST. Improving Peer Review: What Reviewers Can Do.. American Journal of Health-System Pharmacists. 74(24):2080-4. doi:10.2146/ajhp170190.

  • Allender JE, Reed BN, Foster JL, Moretz JD, Oliphant CS, Jennings DL, DiDomenico RJ, Coons JC. Pharmacologic considerations in patients receiving left ventricular percutaneous mechanical circulatory support. Pharmacotherapy. . doi:10.1002/phar.1995.

  • DiDomenico RJ. Digoxin remains a viable option to control heart rate in patients with atrial fibrillation.. Canadian Journal of Hospital Pharmacy. 70:391-2. doi:http://dx.doi.org/10.4212/cjhp.v70i5.1701.

  • Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette D, Walton SM. Comparative effectiveness of oral antiplatelet agents in patients with acute coronary syndrome. Pharmacotherapy. 2017;. doi:10.1002/phar.1961.

  • Kim K, Lee TA, Touchette D, DiDomenico RJ, Ardati AK, Walton SM. “Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome”. Journal of Managed Care & Specialty Pharmacy. 2017;23(1):57-63. doi:10.18553/jmcp.2017.23.1.57.

  • Ursan ID, Krishnan JA, Pickard AS, Calhoun E, DiDomenico RJ, Prieto-Centurion V, Sullivan JB, Valentino L, Williams MV, Joo M. “Engaging patients and caregivers to design transitional care management services at a minority serving institution”. Journal of Health Care for the Poor and Underserved. 2016;27(1):352-65. doi:10.1353/hpu.2016.0026.

  • Hanigan S, DiDomenico RJ. Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?. Journal of pharmacy practice. 2016;29(1):46-57. doi:10.1177/1933719115615877.

  • Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette D, Walton SM. Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015;18(7):A376. doi:10.1016/j.jval.2015.09.784.

  • Lose J, Dorsch MP, DiDomenico RJ. Comparison of practice patterns between inpatient cardiology pharmacists with and without added qualifications in cardiology.. Hospital pharmacy. 2015;50(1):51-8. doi:10.1310/hjp5001-051.

  • Nutescu EA, Engle JP, Bathija S, Chan JJ, Mucksavage JH, Ohler KP, Tesoro EJ, Thielke JL, Shapiro NJ, Donnelly A, Garofalo JJ, DiDomenico R. Balance of academic responsibilities of clinical track pharmacy faculty in the United States: a survey of select American College of Clinical Pharmacy Practice and Research Network Members.. Pharmacotherapy. 2014;34(12):1239-49. doi:10.1002/phar.1521.

  • DiDomenico RJ, Bress AP, Na-Thalang K, Tsao YY, Groo VL, Deyo KL, Patel SR, Bishop JR, Bauman J. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.. Pharmacotherapy. 2014;34(11):1121-31. doi:10.1002/phar.1480.

  • Dorsch MP, Lose JM, DiDomenico RJ. The effect of cardiovascular credentialed pharmacists on process measures and outcomes in myocardial infarction and heart failure.. Pharmacotherapy. 2014;34(8):803-8. doi:10.1002/phar.1444.

  • Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, 2nd JH, Patterson O, Vardeny BM, Massie . Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.. Pharmacotherapy. 2013;33(5):529-48. doi:10.1002/phar.1295.

  • Milfred-Laforest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, 2nd JH, Patterson O, Vardeny BM, Massie . Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.. Journal of cardiac failure. 2013;19(5):354-69. doi:10.1016/j.cardfail.2013.02.002.

  • Wiggins BS, Rodgers JE, DiDomenico RJ, Cook AM, Page RL, 2nd . Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy’s Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative.. Pharmacotherapy. 2013;33(5):558-80. doi:10.1002/phar.1231.

  • Perez A, Touchette DJ, DiDomenico RD, Stamos TM, Walton S. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.. Pharmacotherapy. 2011;31(6):552-65. doi:10.1592/phco.31.6.552.

  • Yu S, Galanter WL, DiDomenico RJ, Borkowsky S, Schiff GD, Lambert BL. Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: results of a Delphi survey.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011;68(5):407-14. doi:10.2146/ajhp100215.

  • DiDomenico RJ, Kondos GT, Dickens C. (2010). Letter by DiDomenico et al regarding article, “Recent national trends in readmission rates after heart failure hospitalization”.. Circulation. Heart failure. Vol. 3. Issue 3. Page(s) e13; author reply e17.

  • DiDomenico RJ, Perez AM, Schumann HR, Fontana DT, Kondos GT, Schumock G. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure.. The Annals of pharmacotherapy. 2008;42(3):327-33. doi:10.1345/aph.1K496.

  • Vats VJ, DiDomenico RT, Schumock G. Hospital policies for treatment of acute decompensated heart failure.. The Annals of pharmacotherapy. 2007;41(4):562-7. doi:10.1345/aph.1H664.

  • Bauman J, DiDomenico RJ, Viana M, Fitch M. A method of determining the dose of digoxin for heart failure in the modern era.. Archives of internal medicine. 2006;166(22):2539-45. doi:10.1001/archinte.166.22.2539.

  • Desai SS, Massad MG, DiDomenico RJ, Abdelhady K, Hanhan Z, Lele H, Snow NJ, Geha AS. Recent developments in antithrombotic therapy: will sodium warfarin be a drug of the past?. Recent patents on cardiovascular drug discovery. 2006;1(3):307-16.

  • Bauman J, DiDomenico RJ, Galanter WL. Mechanisms, manifestations, and management of digoxin toxicity in the modern era.. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2006;6(2):77-86.

  • Galanter WL, DiDomenico RJ, Polikaitis A. A trial of automated decision support alerts for contraindicated medications using computerized physician order entry.. Journal of the American Medical Informatics Association : JAMIA. 2005;12(3):269-74. doi:10.1197/jamia.M1727.

  • DiDomenico RJ, Massad MG, Kpodonu J, Navarro RA, Geha AS. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.. Chest. 2005;127(5):1828-35. doi:10.1378/chest.127.5.1828.

  • DiDomenico RJ, Massad MG. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery.. The Annals of thoracic surgery. 2005;79(2):728-40. doi:10.1016/j.athoracsur.2004.03.037.

  • Eckhoff CD, DiDomenico RJ, Shapiro NL. Initiating warfarin therapy: 5 mg versus 10 mg.. The Annals of pharmacotherapy. 2004;38(12):2115-21. doi:10.1345/aph.1E083.

  • Galanter WL, Polikaitis A, DiDomenico RJ. A trial of automated safety alerts for inpatient digoxin use with computerized physician order entry.. Journal of the American Medical Informatics Association : JAMIA. 2004;11(4):270-7. doi:10.1197/jamia.M1500.

  • DiDomenico RJ, Park HY, Southworth MR, Eyrich HM, Lewis RK, Finley JM, Schumock GT. Guidelines for acute decompensated heart failure treatment.. The Annals of pharmacotherapy. 2004;38(4):649-60. doi:10.1345/aph.1D481.

  • DiDomenico RJ. (2004). Randomized trial of warfarin nomograms.. Annals of internal medicine. Vol. 140. Issue 6. Page(s) 489-90; author reply 491-2.

  • DiDomenico RJ, Eyrich HM. (2003). Did contrast nephropathyin RAPPID really occur?. Journal of the American College of Cardiology. Vol. 42. Issue 12. Page(s) 2167; author reply 2167-9.

  • DiDomenico RJ. Reimbursement mechanisms for glycoprotein IIb/IIIa-receptor inhibitors.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2002;59(21 Suppl 7):S37-42.

  • Galanter WL, DiDomenico RJ, Polikaitis A. Preventing exacerbation of an ADE with automated decision support.. Journal of healthcare information management : JHIM. 2002;16(4):44-9.

  • Bauman J, DiDomenico RJ. Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death.. Journal of cardiovascular pharmacology and therapeutics. 2002;7(3):195-202.

  • Schoen MD, DiDomenico RJ, Connor SE, Dischler JE, Bauman J. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.. Pharmacotherapy. 2001;21(12):1455-63.

  • DiDomenico RJ, Walton SM, Sanoski CA, Bauman J. Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.. Journal of cardiovascular pharmacology and therapeutics. 2000;5(2):77-85.

  • DiDomenico RJ. New antithrombotics for the intensive care unit setting: GP IIb/IIIa inhibitors, low-molecular-weight heparins, and direct thrombin inhibitors.. Critical care nursing quarterly. 2000;22(4):61-74.

    • Notable Honors

    2017, Fellow, American College of Cardiology

    2017, Fellow, Heart Failure Society of America

    2015, Fellow, American College of Clinical Pharmacy

    Education

  • Other, Cardiovascular Pharmacotherapy Fellowship, Cardiovascular pharmacotherapy, University of Illinois at Chicago, Chicago, IL

  • Other, Pharmacy Practice Residency, University of Illinois at Chicago, Chicago, IL

  • PharmD, University of Illinois at Chicago College of Pharmacy, Chicago, IL

    • Licensures and Certifications

  • Board of Pharmaceutical Specialties, Added Qualifications in Cardiology (AQ Cardiology), 2015

  • Board of Pharmaceutical Specialties, Board Certified Pharmacotherapy Specialist (BCPS), 2015

  • American Heart Association, Advanced Cardiac Life Support, 2013

  • American Heart Association, Basic Life Support for Healthcare Providers

  • State of Illinois Dept. of Financial & Professional Regulation, Registered Pharmacist

    • Professional Memberships

  • Board of Pharmacy Specialties

  • American College of Clinical Pharmacy

  • American College of Cardiology

  • Heart Failure Society of America

  • Rho Chi Society, Phi Chapter

  • American College of Clinical Pharmacy

  • American Society of Health-System Pharmacists